¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Free Form Amino Acid Complex Oral"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • cysteic acid
    ½Ã½ºÅ×Àλê
  • calcium ethylenediaminetetraacetic acid
    Ä®½·¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
  • chamber acid
    ¿¬½ÇȲ»ê
  • chenodeoxycholic acid
    Äɳ뵥¿Á½ÃÄÝ»ê
  • chitonic acid
    Űſ»ê
  • cholic acid
    ´ãÁó»ê
  • delta-aminolevulinic acid
    µ¨Å¸¾Æ¹Ì³ë·¹ºÒ¸°»ê
  • deoxycholic acid
    µ¥¿Á½ÃÄÝ»ê
  • deoxyribonucleic acid
    µ¥¿Á½Ã¸®º¸ÇÙ»ê, DNA
  • desoxyribonucleic acid
    µ¥¿Á½Ã¸®º¸ÇÙ»ê, DNA
  • dibasic acid
    ÀÌ¿°±â»ê
  • dicarboxylic acid
    µðÄ«¸£º¹½Ç»ê
  • dilute acid
    ¹±Àº»ê
  • essential fatty acid
    ÇʼöÁö¹æ»ê
  • ethylenediamine tetraacetic acid
    ¿¡Æ¿·»µð¾Æ¹Î»ç¾Æ¼¼Æ®»ê
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • glyceric acid
    ±Û¸®¼¼¸°»ê
  • glycocholic acid
    ±Û¸®ÄÚÄÝ»ê
  • glycolic acid
    ±Û¸®ÄÝ»ê
  • heteropoly acid
    ÇìÅ׷δÙÁß»ê
  • hippuric acid
    È÷Ǫ¸£»ê, ¸¶´¢»ê
  • humic acid
    È޹λê
  • hyaluronic acid
    È÷¾Ë·ç·Ð»ê
  • hydrochloric acid
    ¿°»ê
  • hydrocyanic acid
    È÷µå·Î½Ã¾È»ê
  • hydrofluoric acid
    ºÒÈ­¼ö¼Ò»ê
  • hydroxyindoleacetic acid
    È÷µå·Ï½ÃÀε¹¾Æ¼¼Æ®»ê
  • inosinic acid
    À̳ë½Å»ê
  • isothiocyanic acid
    ÀÌ¼ÒÆ¼¿À½Ã¾È»ê
  • ketonic acid
    ÄÉÅæ»ê
  • lactic acid
    Á¥»ê, ¶ôÆ®»ê
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • acid tide
    »êÁõ°¡±â.
  • acid value
    »ê°ª, »ê°¡(߫ʤ).
  • acid, dipicolinic
    µðÇÇÄݸ°»ê
  • acid, lipoteichoic
    ÁöÁúŸÀÌÄÚ»ê
  • acid, membrane teichoic
    ¸·¼ºÅ¸ÀÌÄÚ»ê
  • acid, muramic
    ¹Â¶ó¹Í»ê
  • acid, teichoic
    ŸÀÌÄÚ»ê
  • acid, teichuronic
    ŸÀÌÅ¥·Ð»ê
  • acid, ¥â-hydroxymyristic
    º£Å¸ÇÏÀ̵å·Ï½Ã¹Ì¸®½ºÆ¾»ê
  • acid-base buffer system
    »ê¿°±â¿ÏÃæ°è
  • acid-base compensation
    »ê¿°±â º¸»ó
  • acid-base indicator
    »ê¿°±âÁö½Ã¾à
  • acid-fast bacillus
    Ç×»ê±Õ(ù÷߫ж)
  • acid-fast stain
    Ç׻꼺 ¿°»ö
  • acid-fast stain
    Ç׻꼺¿°»ö(ù÷ß«àõæøßä)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • free cortisol
    À¯¸®(ë´ìÆ)ÄÚ¸£Æ¼Á¹.
  • free diffusion
    ÀÚÀ¯È®»ê.
  • free edge
    ÀÚÀ¯ º¯¿¬ºÎ
  • free electron
    ÀÚÀ¯ÀüÀÚ
  • free electron
    ÀÚÀ¯ÀüÀÚ(í»ë¦ï³í­).
  • free end saddle partial denture
    À¯¸®´Ü±¹ºÎÀÇÄ¡.
  • free energy
    ÀÚÀ¯(í»ë¦)¿¡³ÊÁö.
  • free erythrocyte porphyrin
    À¯¸®ÀûÇ÷±¸Æ÷¸£ÇǸ°
  • free flap
    À¯¸®ÇÇÆÇ
  • free floating anxiety
    ¶°µ¹ÀÌºÒ¾È (~ÝÕäÌ)
  • free from relapse
    ¹«Àç¹ß
  • free gingiva
    À¯¸®Ä¡Àº(ë´ìÆöÍó»).
  • free graft
    À¯¸®À̽Ä(ë´ìÆì¹ãÕ).
  • free graft
    À¯¸®À̽Ä(À¯ÀÌÀ̽Ä).
  • free grafting
    À¯¸®À̽Ä(¼ú)(¡­âú).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • deoxyguanylic acid
    µ¥¿Á½Ã±¸¾Æ´Ò»ê(ß«)
  • deoxyribonucleic acid
    µ¥¿Á½Ã¶óÀ̺¸ÇÙ»ê(ß«)
  • deoxyribose nucleic acid
    "µ¥¿Á½Ã¶óÀ̺¸½º ÇÙ»ê(ú·ß«), (ÔÒ) deoxyribonucleic acid"
  • deoxythymidylic acid
    "µ¥¿Á½ÃŸÀ̵̹ô»ê(ß«), (ÔÒ) thymidylic acid"
  • deoxyuridylic acid
    µ¥¿Á½ÃÀ¯¸®µô»ê
  • deuridylic acid
    Å»(÷­)À¯¸®µô »ê(ß«)
  • dicarboxylic acid cycle
    "ÀÌ(ì£)Ä«¸£º¹½Ç»ê(ß«) ȸ·Î(üÞÖØ), (ÔÒ) glyoxylate cycle"
  • "2,4-dichlorophenoxyacetic acid"
    "2,4-ÀÌ(ì£)¿°¼Ò(ç¤áÈ)Æä³ì½Ã¾Æ¼¼Æ®»ê(ß«)"
  • "2,6-dichlorophenoxyacetic acid"
    "2,6-ÀÌ(ì£)¿°¼Ò(ç¤áÈ)Æä³ì½Ã¾Æ¼¼Æ®»ê(ß«)"
  • "2,5-dihydroxyphenylacetic acid"
    "2,5-ÀÌ(ì£)ÇÏÀ̵å·Ï½ÃÆä´Ò¾Æ¼¼Æ®»ê(ß«) (ÔÒ) homogentisic acid"
  • "1,3-diphosphoglyceric acid"
    "1,3-ÀÌÀλê(ì£×òß«)±Û¸®¼¼¸°»ê(ß«), (ÔÒ) 1,3-bisphosphoglycerate"
  • "2,3-diphosphoglyceric acid"
    "2,3-ÀÌÀλê(ì£×òß«)±Û¸®¼¼¸°»ê(ß«), (ÔÒ) 2,3-bisphosphoglycerate"
  • dipicolinic acid
    µðÇÇÄݸ®´Ñ»ê(ß«)
  • diprotic acid
    À̾çÀÚ »ê(ì£åÕí­ß«)
  • eleostearic acid
    Àϸ®¿À½ºÅ׾Ƹ£»ê(ß«)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
cDGS complete form of DiGeorge syndrome
CEEF clinical evaluation encounter form
CKS classic form of Kaposi sarcoma
CRF case report form; chronic renal failure; chronic respiratory failure; coagulase-reacting factor; con...
CTMM-SF California Test of Mental Maturity-Short Form
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
CDAA choline deficient L-amino acid defined
GABA-B gamma amino butyric acid type B
IAA indispensable amino acid
NEAA non-essential amino acid
PAS para amino salicylic acid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acid-base balance disturbance
    »ê ¿°±â ÆòÇü ÀÌ»ó
    »ê°ú ¿°±âÀÇ ÆòÇüÀÌ ±úÁø »óÅÂ.
  • acid-base compensation
    »ê ¿°±â º¸»ó
  • acid-base indicator
    »ê ¿°±â Áö½Ã¾à
  • acid-fast nonmotile rod
    Ç׻꼺 ºñ¿îµ¿¼º °£±Õ
  • acid-gel application
    °ÖÇü »ê Àû¿ë
  • adenylic acid deaminase
    ¾Æµ¥´Ò»ê Å»¾Æ¹Ì³ë È¿¼Ò
  • aldobionic acid
    ¾Ëµµºñ¿Â»ê
    C11H19O10COOH. ±× ¼ººÐ´çÀÇ Çϳª·Î¼­ ¿ì·Ð»êÀ» ÇÔÀ¯Çϰí ÀÖ´Â ÀÌ´ç·ùÀ̸ç, ¿©·¯ Á¾·ùÀÇ ½Ä¹°¼º °í¹«¿Í ƯÁ¤ÇÑ º´¿øÃ¼ Áß¿¡ Á¸ÀçÇÑ´Ù. Æó·Å±Õ 3ÇüÀÇ Æ¯¼ö ´Ù´ç·ùÀÇ °¡¼öºÐÇØ¿¡ ÀÇÇØ¼­ ¾òÀ» ¼ö ÀÖ´Ù.
  • allokainic acid
    ¾Ë·ÎÄ«ÀÎ »ê
  • alloxyproteic acid
    ¾Ë·Ï½Ã ´Ü¹é»ê
    ¶§¶§·Î ´¢ Áß¿¡ ¹è¼³µÇ´Â À¯È² ÇÔÀ¯ È­ÇÕ¹°.
  • alpha-oxynaphthoic acid
    ¾ËÆÄ-¿Á½Ã³ªÇÁÅä»ê
    °áÁ¤¼ºÀÇ »ê,OHC10H6COOH.°ú°Å¿¡´Â ¹æºÎÁ¦, ¹æÃëÁ¦·Î »ç¿ëµÇ¾ú´Ù.
  • aminoacetic acid
    ¾Æ¹Ì³ë¾Æ¼¼Æ®»ê, ¾Æ¹Ì³ëÃÊ»ê
    ºñÇʼö ¾Æ¹Ì³ë»ê, NH2CH2COOH. ¸¹Àº ´Ü¹éÁúÀÇ ±¸¼º ¼ººÐÀ¸·Î Á¸ÀçÇÑ´Ù. ÇÕ¼ºµÇ°í ÀÖÀ¸¸ç À§ Á¦»êÁ¦¿Í º¸Ãæ½ÄǰÀ¸·Î »ç¿ëµÇ¾îÁø´Ù. ¶ÇÇÑ ¿©·¯ °¡Áö ±ÙÀ°º´ ¹× ¸»ÃÊÇ÷°ü ºÎÀüÁõÀÇ Ä¡·á¿¡µµ »ç¿ëµÈ´Ù.
  • aminobenzoic acid
    ¾Æ¹Ì³ë ¾È½ÄÇâ »ê
    C7H7NO2. ½Ä¹°°ú µ¿¹°Á¶Á÷¿¡ ³Î¸® ºÐÆ÷Çϸç, ºñŸ¹Î B±ºÀÇ ±¸¼º ¼ººÐ¿¡ °ü°èµÈ´Ù. ¼³ÆÄÁ¦ÀÇ Á¤±ÕÀÛ¿ëÀ» ¹«È¿È­½ÃŲ´Ù.
  • arachidonic acid
    ¾Æ¶ó۵·»ê
    1. °íµµÀÇ ºÒÆ÷È­ Çʼö Áö¹æ»ê. CH3
  • arachidonic acid metabolism
    ¾Æ¶ó۵·»ê ´ë»ç¹°Áú
  • arsenic acid
    ºñ»ê
    HAsO©þ. À̰ÍÀÇ ¿°À» ºñ»ê¿°À̶ó°í ºÎ¸£¸ç ÀǾàǰÀ¸·Î ¾²ÀδÙ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
2-amino-5-phosphonovalerate <chemical> A potent and specific antagonist of nmda receptors (receptors, nmda) in the d-enantiomeric form. The l form is inactive at nmda receptors but may affect the ap4 (2-amino-4-phosphonobutyrate; apb) excitatory amino acid receptors.
Pharmacological action: excitatory amino acid antagonists.
Chemical name: Norvaline, 5-phosphono-
(12 Dec 1998)
(3-(arginyl)amino-4-(4-nitrophenyl)butyryl)-leucyl-prolyl-threonine Pharmacological action: neurotransmitters
Synonym: 2-afb(p-no2)-proctolin, (afb(p-no2)(2))-proctolin
(26 Jun 1999)
8-amino-7-oxononanoate synthase <enzyme> Chemical name: 7-keto-8-aminopelargonic acid synthetase
Registry number: EC 2.3.1.47
Synonym: 7-kap synthetase, 8-amino-7-oxopelargonate synthase, 7-oxo-8-aminononanoate synthase, biof gene product
(26 Jun 1999)
leukoedema, oral A disorder of the buccal mucosa resembling early leukoplakia, characterised by the presence of filmy opalescence of the mucosa in the early stages to a whitish gray cast with a coarsely wrinkled surface in the later stages, associated with intracellular oedema of the spinous or malpighian layer.
(12 Dec 1998)
leukoplakia, oral A white patch seen on the oral mucosa. It is considered a premalignant condition and is often tobacco-induced. When evidence of epstein-barr virus is present, the condition is called hairy leukoplakia (leukoplakia, hairy).
(12 Dec 1998)
lichen planus, oral Oral lesions accompanying cutaneous lichen planus or often occurring alone. The buccal mucosa, lips, gingivae, floor of the mouth, and palate are usually affected (in a descending order of frequency). Typically, oral lesions consist of radiating white or gray, velvety, threadlike lines, arranged in a reticular pattern, at the intersection of which there may be minute, white, elevated dots or streaks (wickham's striae).
(12 Dec 1998)
live oral poliovirus vaccine Inactivated poliovirus vaccine (IPV), an aqueous suspension of inactivated strains of poliomyelitis virus (types 1, 2, and 3) used by injection; has largely been replaced by the oral vaccine.
See: Salk vaccine.
(05 Mar 2000)
Rambourg's chromic acid-phosphotungstic acid stain <technique> A stain for glycoproteins, used with an electron microscope, with which ultrathin tissue sections reveal complex carbohydrates in the same locations as shown by Rambourg's periodic acid-chromic methenamine-silver stain.
(05 Mar 2000)
aberrant complex An anomalous electrocardiographic complex, more specifically an abnormal ventricular complex caused by abnormal intraventricular conduction of a supraventricular impulse.
(05 Mar 2000)
activated complex <chemistry> State of highest energy during a reaction. When reactants form the activated complex, bond breaking and bond formation is occurring.
Synonym: transition state.
(09 Jan 1998)
AIDS dementia complex <immunology> A frequent cerebral condition in people with AIDS that results in the loss of cognitive capacity, affecting the ability to function in a social or occupational setting.
Its cause has not been determined exactly, but may result from HIV infection of cells in the brain or an inflammatory reaction to such infection.
(09 Oct 1997)
aids-related complex A prodromal phase of infection with the human immunodeficiency virus (HIV). Laboratory criteria separating aids-related complex (arc) from aids include elevated or hyperactive B-cell humoral immune responses, compared to depressed or normal antibody reactivity in aids; follicular or mixed hyperplasia in arc lymph nodes, leading to lymphocyte degeneration and depletion more typical of aids; evolving succession of histopathological lesions such as localization of kaposi's sarcoma, signaling the transition to the full-blown aids.
(12 Dec 1998)
alpha-ketoglutarate dehydrogenase complex alpha-ketoglutarate dehydrogenase
amygdaloid complex Almond-shaped group of basal nuclei anterior to the inferior horn of the lateral ventricle of the brain, within the temporal lobe. The amygdala is part of the limbic system.
(12 Dec 1998)
anomalous complex A complex in the electrocardiogram differing significantly from the physiologic type in the same lead.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á